May 27, 2021. Shanghai – CEIBS and Becton, Dickinson & Company (BD) today signed a memorandum of understanding (MoU) to work together on case development, real-world teaching, student internships/employment and talent training.

CEIBS Vice President and Dean Ding Yuan stated during the ceremony at the school’s Shanghai campus that he is looking forward to co-operating with BD Medical.

“We believe that both parties can benefit from case development and knowledge creation – there is a lot we can do together,” he said.

Prof. Ding added that partnerships with some of the world’s top case libraries – including Harvard and Ivey – ensure that the CEIBS’ cutting-edge management knowledge will continue to contribute to global business education and economic development.

“Every year, CEIBS professors develop many in-depth cases around outstanding companies, and help summarise and refine their innovative practices and management experience,” he said.

BD Global Senior Vice President and Greater China Region General Manager Deng Jianmin echoed Prof. Ding’s words during the event and expressed his confidence in the new co-operation.

“BD Medical can provide CEIBS with rich medical professional content, while CEIBS can provide excellent talent for BD Medical. I believe this co-operation will create more opportunities for both parties,” he said.

An alumnus from the CEIBS EMBA Class of 1996, Mr. Deng is active in the development of the school’s alumni community and credits CEIBS with playing a pivotal role in the advancement of his career.

“I was able to successfully transition from being a doctor to being a corporate leader, and I couldn’t have done this without studying at CEIBS. I’m very happy to promote this co-operation and to continue to give back to the school,” he said.

Mr. Deng also serves as President of the Shanghai Jing’an Branch of the CEIBS Alumni Association and Honorary President of the Medical Device IVD Special Committee of the Alumni Medical and Health Industry Association.

About BD  

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.